Dark

Check out our API

AGRX
AGILE THERAPEUTICS INC
stock OTC

Inactive

Aug 26, 2024

1.51USD0.000%(0.00)120,938

Pre-market

0.00USD-100.000%(-1.51)0

After-hours

0.00USD0.000%(0.00)0

OverviewHistoricalExchangesShortsNews

Jan 12, 2022

05:33PM EST Agile Therapeutics CEO Comments On New Gov't. Guidance Reinforcing Requirement To Cover Contraceptives Determined To Be Medically Appropriate For No Cost Benzinga

05:29PM EST Agile Therapeutics Acknowledges New Government Guidance GlobeNewswire Inc

Jan 10, 2022

08:06AM EST Agile Therapeutics, Afaxys Report Partnership To Expand Access To Twirla Transdermal System, No Terms Disclosed Benzinga

08:01AM EST Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced a new alliance with Afaxys Pharma, LLC to promote Twirla (levonorgestrel and ethinyl estradiol) transdermal system. GlobeNewswire Inc

Jan 5, 2022

08:03AM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive OfficerAl Altomariwill present at the virtual 40th Annual J.P. Morgan Healthcare Conference on Thursday, January 13 at 7:30 a.m. ET. GlobeNewswire Inc

08:01AM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive OfficerAl Altomariwill present at the H.C. Wainwright BioConnect Virtual Conference taking place January 10-13, 2022, and at Biotech Showcase taking place January 10-12, 2022. GlobeNewswire Inc

Nov 3, 2021

09:14AM EDT HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Lowers Price Target to $2.5 Benzinga

Nov 2, 2021

05:58PM EDT Agile Therapeutics Q3 EPS $(0.18) Beats $(0.19) Estimate, Sales $1.29M Miss $1.46M Estimate Benzinga

10:41AM EDT Earnings Scheduled For November 2, 2021 Benzinga

Oct 22, 2021

08:01AM EDT Agile Therapeutics, Inc.(Nasdaq: AGRX), a womens healthcare company, today announced it will report third quarter 2021 financial results after the market close onTuesday, November 2, 2021 as follows: GlobeNewswire Inc

Oct 18, 2021

06:44AM EDT The following are some of the stocks making big moves in Monday's pre-market trading (as of 06.30 A.M. EDT). RTTNews

Oct 16, 2021

01:15PM EDT The Past Week's Notable Insider Buys Included Digitalbridge, Life Time, A SPAC And More Benzinga

Oct 15, 2021

04:10PM EDT Agile Therapeutics Shares Spike Higher; Co Reports Executive Edelman Joseph Buys ~8.42M Shares At Average Price Of $0.58 Benzinga

Oct 12, 2021

08:01AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today applauded House Congressional Committee leaders in urging theSecretaries of U.S.Departments of Health and Human Services (HHS), Treasury, and Labor to enforce the law regarding womens access to contraceptive methods asdictated by theAffordable Care Act (ACA). GlobeNewswire Inc

Oct 8, 2021

04:05PM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced that Josephine Torrente has been appointed to the Companys board of directors, as a Class II director, effective as of October 7, 2021. Ms. Torrente will serve on Agiles Science and Technology Committee and Nominating and Corporate Governance Committee. GlobeNewswire Inc

02:36PM EDT Mid-Afternoon Market Update: Dow Surges 80 Points; ChemoCentryx Shares Spike Higher Benzinga

12:30PM EDT Mid-Day Market Update: Crude Oil Rises 2%; Allogene Therapeutics Shares Plunge Benzinga

10:12AM EDT Agile Therapeutics, Inc. (AGRX) shares are sliding on Friday morning trade after the company announced $22.67 million underwritten public offering of its common stock and warrants at a combined offering price of $0.85. RTTNews

08:33AM EDT Agile Therapeutics Prices $22.666 Underwritten Public Offering At $0.85/Share Benzinga

08:30AM EDT Agile Therapeutics Announces Pricing of $22,666,650 Underwritten GlobeNewswire Inc

07:04AM EDT A Peek Into The Markets: US Stock Futures Edge Higher; All Eyes On Jobs Data Benzinga

Oct 7, 2021

04:06PM EDT Agile Therapeutics Reports Offering Of Common Stock, Warrants, No Size Disclosed Benzinga

04:05PM EDT Agile Therapeutics Announces Proposed Underwritten Public Offering GlobeNewswire Inc

Oct 4, 2021

08:14AM EDT Agile Therapeutics Announces Addition Of Twirla To A Preferred Drug Position On Medi-Cal Formulary Benzinga

08:02AM EDT Agile Therapeutics Announces Addition of Twirla to a GlobeNewswire Inc

Oct 1, 2021

07:56AM EDT The Daily Biotech Pulse: Merck Rallies On Antiviral Pill Data, Gilead Files For Yescarta Label Expansion, Exscientia IPO Benzinga

Sep 28, 2021

08:07AM EDT Agile Therapeutics Partners With , U.S. Women's Soccer Star Carli Lloydr To Bring Awareness To Women's Health Topics Benzinga

08:01AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, announced today a partnership with U.S. Womens Soccer legend, Carli Lloyd. The partnership with Agile will focus on bringing awareness to womens health topics, and Agiles commitment to elevating womens healthcare. GlobeNewswire Inc

Sep 13, 2021

07:59AM EDT 10 Biggest Price Target Changes For Monday Benzinga

06:50AM EDT HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Lowers Price Target to $3.5 Benzinga

Sep 7, 2021

07:30AM EDT Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced that management will present and participate at the following virtual investor conferences during the month of September 2021. GlobeNewswire Inc

Aug 20, 2021

07:42AM EDT Agile Therapeutics Announces Partnership With Telehealth Service Pandia For Co.'s Twirla Birth Control Patch; Financial Details Not Disclosed Benzinga

07:30AM EDT -- Pandia Health is a doctor founded and led telehealth company, offering online prescriptions and free delivery designed to make it easier for women to access birth control options that meet their needs -- Partnership represents first telehealth alliance for Agiles Twirla birth control patch GlobeNewswire Inc

Aug 18, 2021

07:38AM EDT The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline Benzinga

Aug 17, 2021

08:28AM EDT The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business Benzinga

Jul 30, 2021

10:11AM EDT 2 Penny Stocks Insiders Are Buying Benzinga

Jul 29, 2021

05:48AM EDT Agile Therapeutics CFO Dennis Reilly Reported Purchase of 50,000 Shares @ Avg Price of $1.08/Share in Form 4 Filing on Wednesday Benzinga

Jul 28, 2021

07:33AM EDT The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal Benzinga

Jul 27, 2021

11:13AM EDT RBC Capital Maintains Outperform on Agile Therapeutics, Lowers Price Target to $5 Benzinga

Jul 26, 2021

04:58PM EDT Agile Therapeutics: Q2 Earnings Insights Benzinga

04:33PM EDT Agile Therapeutics Q2 EPS $(0.20) Beats $(0.21) Estimate; Total Prescriptions Up 171% Benzinga

04:05PM EDT Agile Therapeutics Reports Second Quarter 2021 Financial Results GlobeNewswire Inc

04:40AM EDT Earnings Scheduled For July 26, 2021 Benzinga

Jul 25, 2021

10:05AM EDT The Week Ahead In Biotech (July 25-31): Big Pharma Earnings, Iterum FDA Decision, Alzheimer's Conference, IPOs and More Benzinga

Jul 20, 2021

08:20AM EDT The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street Benzinga

Jul 9, 2021

07:36AM EDT The Daily Biotech Pulse: Lilly, Morphic's Positive Data At ECCO, Humanigen's COVID Treatment Gets Expedited Review In UK, TransCode IPO Benzinga

Jul 7, 2021

07:41AM EDT The Daily Biotech Pulse: Opiant Spikes On Data, OncoSec Rallies On Merck Collaboration, XBiotech Special Dividend Benzinga

Jul 1, 2021

08:05AM EDT Agile Therapeutics, Inc.(Nasdaq: AGRX), a womens healthcare company, today announced it will report second quarter 2021 financial results after the market close onMonday, July 26, 2021 as follows: GlobeNewswire Inc

May 26, 2021

08:05AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced the company will be participating virtually in the William Blair 41st Annual Growth Stock Conference. GlobeNewswire Inc

May 12, 2021

08:57AM EDT The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron Benzinga

08:00AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a womens healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat as part of the 2021 RBC Capital Markets Global Healthcare Conference on Wednesday, May 19, 2021 at 1:20 p.m. ET. GlobeNewswire Inc

May 11, 2021

07:54AM EDT The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings Benzinga

May 6, 2021

07:49AM EDT The Daily Biotech Pulse: Merck's Keytruda Snags Another FDA Approval, Moderna Slips On Revenue Miss, Chemocentryx Adcom Benzinga

May 5, 2021

07:43AM EDT The Daily Biotech Pulse: Athenex, NeoGenomics And Amryt In M&A Mix, European Nod For Roche's Cancer Immunotherapy, Earnings Deluge Continues Benzinga

May 4, 2021

05:24PM EDT Recap: Agile Therapeutics Q1 Earnings Benzinga

04:19PM EDT Agile Therapeutics Q1 EPS $(0.20) Beats $(0.21) Estimate Benzinga

04:05PM EDT Agile Therapeutics Reports First Quarter 2021 Financial Results GlobeNewswire Inc

08:10AM EDT The Daily Biotech Pulse: Vaxart Rebounds On Strong Vaccine Data, Pfizer's Beat-And-Raise Quarter, BioLineRx Data Benzinga

Apr 30, 2021

11:02AM EDT Agile Therapeutics Announces Presentation Of Safety And Efficacy Data Of Twirla (Levonorgestrel And Ethinyl Estradiol) Transdermal System In Women Of Differing BMI Categories At ACOG Annual Meeting Benzinga

11:01AM EDT Agile Therapeutics Announces Presentation of Safety and Efficacy GlobeNewswire Inc

Apr 20, 2021

10:56AM EDT CORRECTING AND REPLACING -- Agile Therapeutics GlobeNewswire Inc

09:31AM EDT Agile Therapeutics, Inc.(Nasdaq: AGRX), a womens healthcare company, today announced it will report first quarter 2021 financial results after the market close onTuesday, May 4, 2021 as follows: GlobeNewswire Inc

Mar 18, 2021

05:04PM EDT Agile Therapeutics Files For $50M Common Stock Offering Benzinga

Mar 5, 2021

07:30AM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and Chief Executive Officer Al Altomari will present at two investor conferences in March. GlobeNewswire Inc

Mar 1, 2021

04:10PM EST Agile Therapeutics Q4 EPS $(0.20) Beats $(0.22) Estimate Benzinga

04:05PM EST Perceptive Advisors Increases Credit Facility to $45 million, with $25 million potentially available GlobeNewswire Inc

03:51AM EST Earnings Scheduled For March 1, 2021 Benzinga

Feb 27, 2021

09:04PM EST The Week Ahead In Biotech (Feb. 28-March 6): KemPharm, Gilead FDA Decisions and More Earnings Benzinga

Feb 25, 2021

01:15PM EST Agile Therapeutics Shares Rebound From Session Low Following Earlier Sam.Beta.gov $250K Contract From Dept. Of Veterans Affairs Benzinga

Feb 19, 2021

08:35AM EST Agile Therapeutics to Host Fourth Quarter and Full Year 2020 GlobeNewswire Inc

Jan 4, 2021

12:18PM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced Chairman and Chief Executive Officer Al Altomari will participate in a fireside chat at the H.C. Wainwright BIOCONNECT 2021 Virtual Conference. GlobeNewswire Inc

Dec 21, 2020

07:30AM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced the Company will present at the 39th Annual J.P. Morgan Healthcare Conference, which is being held virtually, on Thursday, January 14, 2021, at 9:10 a.m. ET. GlobeNewswire Inc

Dec 8, 2020

06:24AM EST HC Wainwright & Co. Maintains Buy on Agile Therapeutics, Raises Price Target to $7 Benzinga

Dec 7, 2020

07:35AM EST Agile Therapeutics Announces Nationwide Commercial Launch and Availability of Twirla Transdermal System, a New Non-Daily, Non-Invasive Contraceptive Patch Benzinga

07:30AM EST Once-WeeklyTwirla is the first and only contraceptive patch that combines levonorgestrel and ethinyl estradiol (EE) GlobeNewswire Inc

Nov 30, 2020

09:13AM EST Agile Therapeutics Announces Peer-Reviewed Publication Of Phase 3 SECURE Study Results For Twirla Transdermal System In Contraception Benzinga

09:12AM EST Agile Therapeutics Announces Peer-Reviewed Publication of Phase 3 GlobeNewswire Inc

Nov 23, 2020

10:00AM EST Agile Therapeutics, Inc.(Nasdaq: AGRX), a women's healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a virtual fireside chat at the Piper Sandler 32nd Annual Healthcare Conference, being held December 1-3, 2020. GlobeNewswire Inc

Nov 12, 2020

04:14PM EST Agile Therapeutics Q3 EPS $(0.18), Inline; Reports $71.9M In Cash, Cash Equivalents And Marketable Securities As Of Sept. 30 Benzinga

03:18PM EST Notable Earnings Watchlist For Thursday, Nov. 12, 2020 After Market Close: DIS, CSCO, BZH, AGRO, AACG, AGRX, AQN, AMAT Benzinga

07:44AM EST The Daily Biotech Pulse: AstraZeneca's Cancer Drug Flunks COVID-19 Studies, Five Prime On a Roll, Morphosys, Xencor, Incyte Strike Cancer Deal Benzinga

04:18AM EST Earnings Scheduled For November 12, 2020 Benzinga

Nov 8, 2020

03:58PM EST The Week Ahead In Biotech: Supernus, Sanofi Await FDA Decisions Benzinga

12:47PM EST The Week Ahead In Biotech: Earnings, Conference Presentations And IPOs Benzinga

Nov 4, 2020

07:30AM EST Agile Therapeutics to Host Third Quarter 2020 Financial Results GlobeNewswire Inc

Sep 22, 2020

11:40AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a women's healthcare company, today announced that Chairman and CEO Al Altomari will be virtually presenting at the Oppenheimer Fall Healthcare Life Sciences & MedTech Summit on Wednesday, September 23, 2020 at 3:20 PM EDT. GlobeNewswire Inc

Sep 9, 2020

08:00AM EDT Agile Therapeutics, Inc. (Nasdaq: AGRX), a forward-thinking womens healthcare company, today announced that Al Altomari, Chairman and Chief Executive Officer, will participate in a fireside chat at the H.C. Wainwright 22nd Annual Global Investment Virtual Conference on Wednesday, September 16, 2020 at 11:30 a.m. EDT. GlobeNewswire Inc

Sep 8, 2020

08:01AM EDT Agile Therapeutics Announces Virtual Investor/Analyst Day on GlobeNewswire Inc

Sep 2, 2020

09:00AM EDT VisitBirthControlDoneMyWay.com to learn more about some of the many available contraceptive options GlobeNewswire Inc

Aug 17, 2020

08:00AM EDT Agile Therapeutics Strengthens Executive Leadership Team with the GlobeNewswire Inc

Aug 12, 2020

10:49AM EDT Agile Therapeutics shares are trading higher after the company reported better-than-expected Q2 EPS results. Benzinga

Aug 11, 2020

04:06PM EDT Agile Therapeutics Q2 EPS $(0.12) Beats $(0.14) Estimate Benzinga

04:05PM EDT Agile Therapeutics Q2 Loss/share $0.12 Vs. Loss $0.08 Year Ago RTTNews

04:02PM EDT Agile Therapeutics to Participate in Maxim GlobeNewswire Inc

04:01PM EDT Agile Therapeutics Reports Second Quarter 2020 Financial Results GlobeNewswire Inc

04:02AM EDT Earnings Scheduled For August 11, 2020 Benzinga

Jul 21, 2020

07:30AM EDT Agile Therapeutics to Host Second Quarter 2020 Financial Results GlobeNewswire Inc

Share